SIMILARITIES
just like its chinese brothers( edu and suntech), it has the potential
to pop another 40 %. EDU ipoed on sep first week and was ranging
between $20-21. Within a month EDU went to $26-27 range twice.That's
30% additional pop. Suntech(STP) first week price was at 20-21 around
dec 15,2005. by Jan 23, 20006 it was at 40. within a month and half it
doubled.  Looks like wall street takes time to make it decision to make
big jump in these chinese dolls.

GLORIOUS PAST
 Founded 15 years ago, this is well established company.The company has
posted impressive revenue growth of better than 50% year-over-year
since 2003. It reported net income of $20.6 million and revenue of
about $85 million in the six months ended June 30.This is impressive
25% return on investment.

PROMISING FUTURE BY GOOD USE OF IPO MONEY
unlike silicon valey start ups , the ipo money is being used for real
business growth activities and NOT pay off debt , pay VCs etc.
Mindray is investing the majority of the IPO proceeds in opening a new
headquarters and manufacturing facility, which is expected to support
over $1 billion in revenue, adjacent to its current location in China.

COMPETETION
Mindray's pricing strength in supplying medical devices outflanks its
competitors. Mindray has successfully penetrated international markets
by offering comparable quality products at prices up to 30% below its
international competitors because of its low cost China-based
operations.
Through this advantage, Mindray's international sales are quickly
approaching 50% of revenue.

I SEE A BIG FUTURE IN THIS COMPANY. THERE IS NO REASON FOR HOSPITALS
NOT TO BUY AT 30% DISCOUNTED PRICE..IT CAN FLAT OUT BEAT THE
COMPETITION IN ITS GROWING INTERNATIONL MARKET. COMPETITORS DONT HAVE
LOW COST MANUFACTURING IN CHINA. BUT THE REAL ICING IN THE CAKE IS THAT
THIS COMPANY BULDS VERY QUALITY PRODUCT

Mindray's strategy of offering comparable quality products at
discounted prices has produced excellent results.

EDU p/e is 228 and STP p/e is 89. while mr is trading at pe of just 40.
MR posted a yearly revenue of 697 million in 2004. To produce almost
the same amount of revenue (676 milion) it only took a quarter in 2006.
 That's fourfold  increase in 2 years. I am just waiting to see what
this puppy can do with all the ipo money. So my predication that stock
can jump 20 to 40% very soon should be in realm of possibilities.  Had
it been an american company with these kind of fundamentals , american
investors would be paying 4 times the price. Since a lot of american
investors and fund managers are largely ignorant of chinese companies,
it takes a little time to catch their attention. But when they find it
they sure make it POP.

GOOD LUCK and best wishes for the POP